Amentum (AMTM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on March 5, 2025, with stockholders voting on director elections, auditor ratification, executive compensation, and the frequency of future say-on-pay votes.
The company became public in September 2024 via a Reverse Morris Trust transaction, merging Jacobs' CMS business with Legacy Amentum.
Fiscal 2024 highlights: GAAP revenues grew 7% to $8.4B, pro forma revenues up 4% to $13.9B, pro forma net income of $32M, and pro forma adjusted EBITDA up 7% to $1,052M.
Key contract wins include a $45B DOE contract, a $592M NAVSEA contract, and a $1.25B UK MOD framework.
Voting matters and shareholder proposals
Proposals: election of 13 directors, ratification of EY as auditor, advisory vote on executive compensation, and advisory vote on frequency of say-on-pay (board recommends annual).
Board recommends voting FOR all director nominees, FOR auditor ratification, FOR executive compensation, and ONE YEAR for say-on-pay frequency.
Board of directors and corporate governance
Board consists of 13 members, 11 of whom are independent; diverse in skills, gender, and ethnicity.
Board committees (Audit, Compensation, Nominating & Governance) are fully independent.
Annual board and committee evaluations, majority voting standard for uncontested director elections, and no poison pill in effect.
Lead Independent Director and Executive Chair structure; succession planning and talent reviews are conducted annually.
Stockholder recommendations for director nominees are accepted; orientation and continuing education provided for directors.
Latest events from Amentum
- Accelerating growth in nuclear, space, and digital markets drives robust cash flow and margin expansion.AMTM
47th Annual Raymond James Institutional Investor Conference4 Mar 2026 - Net income jumped 267% to $44M on $3.24B revenue, with backlog up 4% to $47.2B.AMTM
Q1 202610 Feb 2026 - All director nominees, audit firm ratification, and executive compensation were approved by majority vote.AMTM
AGM 20269 Feb 2026 - A $14B global leader targets $1.1B EBITDA, 8% margin, and strong growth post-merger.AMTM
Investor Day 20242 Feb 2026 - FY24 pro forma revenue and EBITDA grew post-merger; FY25 guidance and $45B backlog affirmed.AMTM
Q4 202411 Jan 2026 - Board recommends electing 13 directors, ratifying auditor, and approving executive pay.AMTM
Proxy Filing19 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay amid strong performance and governance.AMTM
Proxy Filing19 Dec 2025 - Q1 FY2025 delivered revenue growth, $12M net income, and record backlog, reaffirming guidance.AMTM
Q1 202517 Dec 2025 - Strong integration, cost synergies, and capital-light model drive robust free cash flow growth.AMTM
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202516 Dec 2025